science
plus
.abes.fr
|
explorer
À propos de :
http://hub.abes.fr/bmj/periodical/gut/2010/volume_59/issue_01/w
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
bibo:Issue
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
work
Issue
New Facet based on Instances of this Class
Attributs
Valeurs
type
work
Issue
Is Part Of
http://hub.abes.fr/bmj/periodical/gut/2010/volume_59
has manifestation of work
http://hub.abes.fr/bmj/periodical/gut/2010/volume_59/issue_01/m/print
http://hub.abes.fr/bmj/periodical/gut/2010/volume_59/issue_01/m/web
Date Copyrighted
2010
Rights
BMJ Publishing Group Ltd and British Society of Gastroenterology. All rights reserved.
© Vicario et al 2010
issue
01
Access Rights
open-access
is
Is Part Of
of
JournalScan
Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites
Muscle-derived cell injection to treat anal incontinence due to obstetric trauma: pilot study with 1 year follow-up
Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis
Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial
Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer
Haematopoietic stem cell recruitment to injured murine liver sinusoids depends on α4β1 integrin/VCAM-1 interactions
Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?
TRP channels: new targets for visceral pain
Comment on: Prospective randomised multicentre trial comparing the clinical efficacy, safety and patient acceptability of circular stapled anopexy with closed diathermy haemorrhoidectomy
Optimum use of diuretics in managing ascites in patients with cirrhosis
Quality assurance measures in rectal cancer: caveat utilitor
Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
Predicting the response to infliximab from trough serum levels
Comparison of staining methods in collagenous colitis
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial
Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study
Transfusion-refractory anaemia in liver cirrhosis
A case of idiopathic portal vein thrombosis?
Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy
Digest
Tailoring the length of antiviral treatment for hepatitis C
Correction
Should we refer diminutive polyps to post-CTC polypectomy?
Authors’ response
Screening for colorectal cancer: flexible sigmoidoscopy and faecal occult blood immunochemical testing. Which test is superior?
Dendritic cells in chronic viral hepatitis B and C: victims or guardian angels?
B cells, IgE and mechanisms of type I hypersensitivity in eosinophilic oesophagitis
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata